Cart
sales@molnova.com
ASCORBYL GLUCOSIDE
CAS No. 129499-78-1
ASCORBYL GLUCOSIDE( 2-O-α-D-Glucopyranosyl-L-ascorbic Acid? )
Catalog No. M21178 CAS No. 129499-78-1
ASCORBYL GLUCOSIDE is a glucoside derivative of ascorbic acid shows anti-cancer activity after enzymatic hydrolysis to ascorbic acid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 96 | In Stock |
|
| 50MG | 156 | In Stock |
|
| 100MG | 248 | In Stock |
|
| 200MG | 356 | In Stock |
|
| 500MG | 563 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameASCORBYL GLUCOSIDE
-
NoteResearch use only, not for human use.
-
Brief DescriptionASCORBYL GLUCOSIDE is a glucoside derivative of ascorbic acid shows anti-cancer activity after enzymatic hydrolysis to ascorbic acid.
-
DescriptionASCORBYL GLUCOSIDE is a glucoside derivative of ascorbic acid shows anti-cancer activity after enzymatic hydrolysis to ascorbic acid.
-
In Vitro——
-
In Vivo——
-
Synonyms2-O-α-D-Glucopyranosyl-L-ascorbic Acid?
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number129499-78-1
-
Formula Weight338.26
-
Molecular FormulaC12H18O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 125 mg/mL (369.54 mM)
-
SMILESO=C1O[C@H]([C@@H](O)CO)C(O)=C1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Miura K et al. 2-O-α-D-Glucopyranosyl-l-ascorbic acid as an antitumor agent for infusion therapy. Biochem Biophys Rep. 2017 Apr 22;10:232-236.
molnova catalog
related products
-
NE 52-QQ57
NE 52-QQ57 is a selective, and orally available antagonist of GPR4(IC50 : 70 nM),with anti-inflammatory activity.
-
Bractoppin
Bractoppin is a drug-like inhibitor of phosphopeptide recognition by the human BRCA1 tandem (t)BRCT domain (IC50 = 0.074 μM), which selectively inhibits substrate binding with nanomolar potency in vitro.
-
Dehydrojuncusol
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.
